WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H461369
CAS#: 4914-30-1
Description: Dehydroemetine is a synthetically produced antiprotozoal agent similar to emetine in its anti-amoebic properties and structure.
Hodoodo Cat#: H461369
Name: Dehydroemetine
CAS#: 4914-30-1
Chemical Formula: C29H38N2O4
Exact Mass: 478.28
Molecular Weight: 478.630
Elemental Analysis: C, 72.77; H, 8.00; N, 5.85; O, 13.37
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Dehydroemetine; BT 436; BT-436; BT436; Mebadin; Ro 1-9334; Ro-1-9334; Ro1-9334;
IUPAC/Chemical Name: 2-((6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-3-ethyl-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline
InChi Key: XXLZPUYGHQWHRN-UHFFFAOYSA-N
InChi Code: InChI=1S/C29H38N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,24-25,30H,6-12,17H2,1-5H3
SMILES Code: COC1=CC2=C(C=C1OC)CCNC2CC3=C(CC)CN4CCC5=CC(OC)=C(OC)C=C5C4C3
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 478.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: POWELL SJ, MACLEOD IN, WILMOT AJ, ELSDON-DEW R. THE TREATMENT OF ACUTE AMOEBIC DYSENTERY: TRIALS OF DEHYDROEMETINE, OF DEHYDROEMETINE-BISMUTH-IODIDE, AND OF DEHYDROEMETINE AND DEHYDROEMETINE-BISMUTH-IODIDE IN COMBINATION. Ann Trop Med Parasitol. 1965 Jun;59:205-7. PubMed PMID: 14345285.
2: Salako LA. The actions of dehydroemetine on isolated guinea-pig atria. Influence of ouabain and calcium. Br J Pharmacol. 1972 Dec;46(4):725-35. PubMed PMID: 4655270; PubMed Central PMCID: PMC1666376.
3: Jain NK, Madan A, Sharma TN, Sharma DK, Mandhana RG. Hepatopulmonary amoebiasis. Efficacy of various treatment regimens containing dehydroemetine and/or metronidazole. J Assoc Physicians India. 1990 Apr;38(4):269-71. PubMed PMID: 2202709.
4: Durotoye AO, Salako LA. The effect of dehydroemetine on isolated guinea-pig atria. Br J Pharmacol. 1972 Apr;44(4):723-31. PubMed PMID: 5041451; PubMed Central PMCID: PMC1665990.
5: Miller HH, Johnson RK, Donahue JD, Jondorf WR. Hepatic drug-metabolizing enzyme activity in rats pretreated with (-)-emetine or (plus or minus)-2,3-dehydroemetine. Biochem J. 1970 Apr;117(3):491-8. PubMed PMID: 4392930; PubMed Central PMCID: PMC1178951.
6: SARDESAI HV, SULE CR, GAVANKAR SS. Clinical trials with dehydroemetine (Ro 1-9334) in acute amebiasis. Indian J Med Sci. 1963 Apr;17:334-45. PubMed PMID: 13991475.
7: NANAVATI MB, DAMANY SJ, JOSHI HD. CLINICAL TRIAL OF DEHYDROEMETINE (RO 1-9334) IN AMOEDIASIS. Indian Pract. 1965 Mar;18:259-63. PubMed PMID: 14292163.
8: POWELL SJ, WILMOT AJ, MACLEOD IN, ELSDON-DEW R. DEHYDROEMETINE IN THE TREATMENT OF AMOEBIC LIVER ABSCESS. Ann Trop Med Parasitol. 1965 Jun;59:208-9. PubMed PMID: 14345286.
9: KAPADIA RM. CARDIOVASCULAR TOXICITY OF DEHYDROEMETINE IN AMOEBIASIS. J Indian Med Assoc. 1964 Nov 16;43:461-4. PubMed PMID: 14250826.
10: Hernandez-Perez E. Dehydroemetine therapy for herpes zoster. A comparison with corticosteroids. Cutis. 1980 Apr;25(4):424-6. PubMed PMID: 6102504.
11: Seshadri MS, John L, Varkey K, Koshy TS. Ventricular tachycardia in a patient on dehydroemetine and chloroquine for amoebic liver abscess. Med J Aust. 1979 May 5;1(9):406-7. PubMed PMID: 38383.
12: MUNZER D. EVALUATION OF THE EFFECTS OF DEHYDROEMETINE IN AMEBIASIS. Am J Gastroenterol. 1965 Jan;43:49-55. PubMed PMID: 14252602.
13: PATEL JC, DOSHI JC, DEHEJIA HV, BHARUCHA PE, DESHPANDE N. DEHYDROEMETINE IN THE TREATMENT OF AMOEBIASIS. A PRELIMINARY REPORT. J Indian Med Assoc. 1965 May 1;44:467-70. PubMed PMID: 14299042.
14: Farjo P. Dehydroemetine 'Roche' in amebic dysentery and amebic hepatitis in Iraq. Bull Endem Dis (Baghdad). 1964 Jun;6(1):70-4. PubMed PMID: 5825975.
15: Fouarge M, Dewulf M, Couvreur P, Roland M, Vranckx H. Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis. J Microencapsul. 1989 Jan-Mar;6(1):29-34. PubMed PMID: 2565955.
16: Johnson RK, Wynn WT, Jondorf WR. Some aspects of the metabolism of 14C-labelled ( ) 2,3-dehydroemetine in the rat. Biochem J. 1971 Nov;125(2):26P-27P. PubMed PMID: 5144725; PubMed Central PMCID: PMC1178135.
17: Gulati OD, Makol R, Shah DS. Some characteristics of the adrenergic neurone blocking action of dehydroemetine. Br J Pharmacol. 1973 Jun;48(2):314-7. PubMed PMID: 4733732; PubMed Central PMCID: PMC1776205.
18: Rubidge CJ, Scragg JN, Powell SJ. Treatment of children with acute amoebic dysentery. Comparative trial of metronidazole against a combination of dehydroemetine, tetracycline, and diloxanide furoate. Arch Dis Child. 1970 Apr;45(240):196-7. PubMed PMID: 4315969; PubMed Central PMCID: PMC2020286.
19: PILLER M, STOHLER H. [Experimental bases of treatment of amebiasis with Dehydroemetine]. Praxis. 1963 Mar 7;52:273-5. German. PubMed PMID: 13943607.
20: Durotoye AO. The effect of dehydroemetine on vascular tissue. West Afr J Pharmacol Drug Res. 1976 Dec;3(2):119-27. PubMed PMID: 19879.
